113
Participants
Start Date
September 21, 2006
Primary Completion Date
March 31, 2009
Study Completion Date
March 31, 2009
C1 esterase inhibitor [human] (C1INH-nf)
Mount Sinai School of Medicine, New York
Montefiore Medical Center, The Bronx
Winthrop University Hospital, Mineola
Penn State University, Hershey
Institute for Asthma and Allergy, Wheaton
Cornerstone Healthcare, Parkersburg
Allergy Partners of the Upstate, Greenville
Family Allergy and Asthma Center, Atlanta
Orlando Regional Healthcare, Orlando
Allergy and Asthma Center, Fort Lauderdale
Allergy & Asthma Centre of Dayton, Centerville
Welborn Clinic Allergy and Immunology, Evansville
Grand Traverse Allergy, Traverse City
MeritCare Clinical Research, Bemidji
MeritCare Clinical Research, Fargo
Allergy and Asthma Clinic of Northwest Arkansas, Bentonville
Allergy Clinic of Tulsa, Tulsa
AARA Research Center, Dallas
Baylor College of Medicine, Houston
Allergy and Asthma Research Center, San Antonio
Allergy and Immunology Associates, Scottsdale
Nevada Access to Research and Education Society, Las Vegas
UCLA-David Geffen School of Medicine, Los Angeles
Allergy and Asthma Clinical Research, Inc, Walnut Creek
Allergy Asthma and Dermatology Research Center, Lake Oswego
Marycliff Allergy Specialists, Spokane
University of California, San Diego, San Diego
University of Massachusetts Medical School, Worcester
UMDNJ Asthma and Allergy Research Center, Newark
University of Texas Medical Branch, Galveston
Lead Sponsor
Shire
INDUSTRY